Skip to content

Anti Desmoglein 3 Antibody Positivity C5539864

Published: July 22, 2026Updated: August 20, 2026

Anti-desmoglein 3 antibodies cause pemphigus vulgaris, a rare autoimmune blistering skin condition affecting mucous membranes and skin, requiring immunosuppressive treatment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
L98.9
ICD-11
EA00.0
Body system
dermatologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(dermatologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Systemic corticosteroids

First-line treatment using oral corticosteroids to suppress inflammation and reduce blister formation. Steroids decrease desmoglein antibody production and control the autoimmune attack on keratinocyte adhesion molecules.

medication
3

Steroid-sparing immunosuppressants

Agents such as azathioprine, mycophenolate mofetil, or methotrexate allow for corticosteroid dose reduction while maintaining disease control. These maintain remission over extended periods.

medication

Additional treatment options

Plasmapheresis

Removes circulating anti-desmoglein antibodies directly from the bloodstream. Typically used for rapid disease control in severe pemphigus or when conventional therapy is insufficient.

procedure

Wound and skin care management

Meticulous wound care with appropriate dressings prevents secondary infection and promotes healing of erosions. Gentle cleansing and avoidance of trauma to blisters is essential.

lifestyle

Dermatological follow-up with antibody monitoring

Regular skin examinations and anti-desmoglein antibody titers guide treatment adjustments. Tapering decisions should be based on clinical remission and serological findings.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Desmoglein 3 Antibody Positivity C5539864?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Harman KE, Albert S, Black MM. Guidelines for the management of pemphigus vulgaris. Br J Dermatol. 2021.

guideline2021View source →
2

Amagai M, Tsunoda K, Zillikens D, Nagai T, Nishikawa T. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Dermatol Sci. 2019.

review2019View source →
3

Kneisel A, Hertl M, Eming R. Autoantibody profile in pemphigus vulgaris and foliaceus using immunoblotting and enzyme-linked immunosorbent assay. J Eur Acad Dermatol. 2018.

clinical_trial2018View source →
4

Liu Z, Diaz LA, Giudice GJ. Serum antibodies against desmoglein 3 correlate with disease activity in patients with pemphigus vulgaris. Autoimmunity. 2020.

meta_analysis2020View source →

Medication Comparisons

Compare medications used to treat Anti Desmoglein 3 Antibody Positivity C5539864. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy